It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Breast lesions with uncertain malignant behavior, also known as high-risk or B3 lesions, are composed of a variety of pathologies with differing risks of associated malignancy. While open excision was previously preferred to manage all high-risk lesions, tailored management has been increasingly favored to reduce overtreatment and spare patients from unnecessary anxiety or high healthcare costs associated with surgical excision. The purpose of this work is to provide the reader with an accurate overview focused on the main high-risk lesions of the breast: atypical intraductal epithelial proliferation (atypical ductal hyperplasia), lobular neoplasia (including the subcategories lobular carcinoma in situ and atypical lobular hyperplasia), flat epithelial atypia, radial scar and papillary lesions, and phyllodes tumor. Beyond merely presenting the radiological aspects of these lesions and the recent literature, information about their potential upgrade rates is discussed in order to provide a useful guide for appropriate clinical management while avoiding the risks of unnecessary surgical intervention (overtreatment).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Messina, Department of Biomedical Sciences and Morphologic and Functional Imaging, Messina, Italy (GRID:grid.10438.3e) (ISNI:0000 0001 2178 8421)
2 ITESM Monterrey, Department of Breast Imaging, Breast Cancer Center TecSalud, Nuevo Leon, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701)
3 University of Messina, Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, Messina, Italy (GRID:grid.10438.3e) (ISNI:0000 0001 2178 8421)
4 Memorial Sloan Kettering Cancer Center, Department of Radiology, Breast Imaging Service, New York, USA (GRID:grid.51462.34) (ISNI:0000 0001 2171 9952); Medical University of Vienna, Department of Biomedical Imaging and Image-Guided Therapy, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)